What Has Been the Growth Trajectory of the Implantable Collamer Lens Market?
The implantable collamer lens market has seen considerable growth due to a variety of factors.
• There has been robust expansion in the size of the implantable collamer lens market in the past few years. Projected growth indicates a rise from $19.53 billion in 2024 to $20.91 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.10%.
Factors contributing to this historic period growth include heightened awareness about vision correction alternatives, a surge in the uptake of minimally invasive procedures, a growing incidence of refractive errors, beneficial reimbursement schemes in prominent regions, and a rise in investments in ophthalmic research.
What Does the Future Hold for the Implantable Collamer Lens Market?
The implantable collamer lens market is expected to maintain its strong growth trajectory in upcoming years.
• The market space for implantable collamer lenses is forecasted to experience significant expansion in the coming years. The market is predicted to escalate to $27.25 billion by 2029, with a compound annual growth rate (CAGR) of 6.84%.
Factors contributing to this forecasted growth include the surging demand for sustained vision correction alternatives, the rising incidence of myopia and astigmatism, an increased emphasis on individualized patient-specific implants, an aging demographic requiring more eye care, and the broadening network of ambulatory surgical centers. Key predictions for the forecast period encompass AI integration in preoperative preparations, the invention of pliable and bio-compatible lens materials, partnerships between lens manufacturers and healthcare providers, breakthroughs in lens material and design technology, and progress in implantable lens technology.
What Are The Core Factors Supporting Growth In Implantable Collamer Lens Market?
An increase in vision disorders is anticipated to propel the implantable collamer lens market. These disorders, which gradually impair visual acuity and eye health, are becoming more widespread globally due to an aging population, extended screen time, and the escalating incidents of conditions like myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) offer a safe and reversible alternative to traditional refractive surgeries like LASIK, effectively correcting vision troubles like hyperopia, myopia, and astigmatism. As per a World Health Organization report in August 2023, over 2.2 billion people worldwide were affected by near or distance vision impairment, with one billion of these cases either preventable or yet to be addressed. Furthermore, according to the Welsh Government's statistics of July 2023, 1,563 new certificates of vision impairment (CVI) were granted in 2021-22, marking a 49.1% increase from the previous year. Thus, the rising incidents of vision disorders are accelerating the implantable collamer lens market expansion. The Impact Of An Aging Population On The Implantable Collamer Lens Market
What Are The Primary Segments In The Global Implantable Collamer Lens Market?
The implantable collamer lens market covered in this report is segmented –
1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User
Subsegments:
1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia
2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia
Pre-Book The Implantable Collamer Lens Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Implantable Collamer Lens Market?
Leading corporations in the Implantable Collamer Lens (ICL) market are aiming to maintain their market competitiveness through innovation and technological advancements in lens technology and securing approvals. The purpose of the Implantable Collamer Lens is to adjust refractive vision mistakes, providing a less invasive answer for myopia and astigmatism. For instance, the U.S. Food and Drug Administration (FDA) granted approval in April 2022 to the EVO/EVO+ Visian Implantable Collamer Lens (EVO) produced by STAAR Surgical Company, a US company that manufactures and sells implantable lenses and accompanying delivery systems. The EVO Visian ICL lens has the capability to correct or diminish myopia in the range from -3.0 D to -20.0 D, and it can also cater to astigmatism fluctuating between 1.0 D and 4.0 D.
Who Are the Key Players in the Implantable Collamer Lens Market?
Major companies operating in the implantable collamer lens market are include:
• STAAR Surgical Company
What Is The Most Dominant Region In The Implantable Collamer Lens Market?
North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
